title: [Prolactinoma is more frequent among men than among women. A dopamine agonist is effective in the treatment].
authors.affiliation: Endokrinologiska kliniken, Karolinska sjukhuset, Stockholm.
authors.forename: A L
authors.initials: AL
authors.lastname: Hulting
authors.forename: C
authors.initials: C
authors.lastname: Muhr
authors.forename: P O
authors.initials: PO
authors.lastname: Lundberg
authors.forename: S
authors.initials: S
authors.lastname: Werner
mesh_terms: D000328:Adult; D000368:Aged; D001971:Bromocriptine / Q000627:therapeutic use*; D015259:Dopamine Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000188:drug therapy* / Q000453:epidemiology; D015175:Prolactinoma / Q000188:drug therapy* / Q000453:epidemiology; D012737:Sex Factors; D013548:Sweden / Q000453:epidemiology
chemical_list: D015259:Dopamine Agents; D001971:Bromocriptine